Infectious Diseases Self-Assessment Program (IDSAP) Book 1: SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship (Cert # L239233)

The target audience for SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship is board-certified infectious diseases pharmacists caring for adult or pediatric patients in the acute or ambulatory setting.

Board certified pharmacists are eligible to receive up to 14 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship I
ACPE #: 0217-9999-23-042-H01-P
Chapter: Osteomyelitis

• Distinguish the most common etiologies of acute and chronic osteomyelitis.
• Analyze the utility of different imaging modalities in the diagnosis of osteomyelitis.
• Design a treatment plan for the adult patient with osteomyelitis.
• Evaluate appropriateness of oral therapy in the treatment of osteomyelitis.
• Assess clinical circumstances in which nonstandard durations of therapy may be appropriate.
• Design a treatment plan for the pediatric patient with osteomyelitis. 

Chapter: Skin and Soft Tissue Infections

• Evaluate patients for the epidemiology, pathophysiology, and risk factors for skin and soft tissue infections (SSTIs).
• Assess patients for common causative pathogens and antibiotic principles for SSTIs.
• Evaluate the clinical presentation, diagnosis, and management of patients with purulent or nonpurulent SSTIs.
• Assess the clinical presentation, diagnosis, and management of bite wound infections, wound infections, and diabetic foot ulcers/infections.
• Justify surgical site infection management and prophylaxis and antimicrobial stewardship opportunities for SSTIs. 

SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship II
ACPE #: 0217-9999-23-043-H01-P

Chapter: Septic Arthritis and Prosthetic Joint Infections

• Evaluate the clinical presentation, diagnostic techniques, and management of septic arthritis.
• Assess the clinical presentation, imaging findings, and diagnostic testing results of a patient presenting with prosthetic joint infection.
• Design a treatment plan with appropriate monitoring for a patient with a prosthetic joint infection.
• Develop a patient-specific transitions of care plan for a patient with a septic arthritis or a prosthetic joint infection. 

Chapter: Stewardship in Dentistry

• Justify the inclusion of dentists in antimicrobial stewardship initiatives.
• Design a patient-specific antibiotic recommendation based on evidence-based guidelines.
• Develop strategies to improve antibiotic prescribing in dental settings. 

SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship III
ACPE #: 0217-9999-23-044-H01-P

Chapter: Outpatient Pediatric Stewardship

• Justify pediatric stewardship strategies in the outpatient setting.
• Apply metrics to measure outpatient antimicrobial prescribing in the pediatric population.
• Evaluate antimicrobial stewardship program strategies that are applied to different illnesses in the pediatric outpatient setting. 

Recorded Webcast: Pediatric Outpatient Antimicrobial Stewardship

• Apply antimicrobial use trends in the outpatient setting and the need for antimicrobial stewardship.
• Evaluate CDC core elements and available toolkits to assist in initiating outpatient antimicrobial stewardship programs.
• Analyze evidence-based outpatient antimicrobial stewardship interventions.
• Justify the role of the clinical pharmacist in respiratory illness treatment. 

SSTI, Bone and Joint Infections, and Outpatient Antimicrobial Stewardship VI
ACPE #: 0217-9999-23-045-H01-P

Interactive Case: Oral Antibiotics for Osteomyelitis

• Assess the benefits of using oral antibiotics for the treatment of osteomyelitis.
• On the basis of patient characteristics, justify the use of oral antibiotics for the treatment of osteomyelitis.
• Analyze data supporting the use of oral antibiotics for osteomyelitis.
• Develop an oral antibiotic therapy plan for a patient with osteomyelitis.
• Demonstrate the role of complex outpatient oral antimicrobial therapy services. 

Interactive Case: Long-Acting Lipoglycopeptides for SSTIs

• Evaluate the available lipoglycopeptides used in the management of skin and soft tissue infections (SSTIs).
• Distinguish which patients may benefit from use of lipoglycopeptides in the management of SSTIs.
• Assess gaps in the use of lipoglycopeptides for treatment of SSTIs.
• Apply principles of antimicrobial stewardship to optimize use of lipoglycopeptides.

Series Editors

Elizabeth S. Dodds Ashley, Pharm.D., MHS, BCIDP
Associate Professor of Medicine
Division of Infectious Diseases
Duke University
School of Medicine Director of Operations
Duke Antimicrobial Stewardship Outreach Network (DASON)
Durham, North Carolina 

Alan E. Gross, Pharm.D., FCCP, BCPS, BCIDP
Clinical Associate Professor
Department of Pharmacy Practice
University of Illinois at Chicago College of Pharmacy
Infectious Diseases Pharmacist
Hospital Pharmacy Services
University of Illinois Hospital and Health Sciences System
Chicago, Illinois

Faculty Panel Chair

P. Brandon Bookstaver, Pharm.D., FCCP, FIDSA, BCIDP
Associate Professor
Director of Residency and Fellowship Training
Department of Clinical Pharmacy and Outcomes Sciences College of Pharmacy
University of South Carolina
Columbia, South Carolina

Authors

David B. Cluck, Pharm.D., BCPS, BCIDP, AAHIVP
Associate Professor of Pharmacy Practice
Department of Pharmacy Practice
East Tennessee State University – Gatton College of Pharmacy
Johnson City, Tennessee 

Robert Daniels, Pharm.D., BCPPS
Pediatric Infectious Disease Clinical Pharmacy Specialist
Department of Pharmacy
Prisma Health Children’s Hospital-Midlands
Columbia, South Carolina 

Rachel Foster, Pharm.D., MBA, BCIDP
Advanced Clinical Pharmacist
Infectious Diseases/Antimicrobial Stewardship
PGY-2 Infectious Diseases Residency Site Coordinator Intermountain Healthcare
Murray, Utah 

Gretchen Gibson, DDS, MPH
Director, Oral Health Quality Group
Office of Dentistry
Veterans Health Administration
Washington, D.C. 

Wesley D. Kufel, Pharm.D., BCPS, BCIDP, AAHIVP
Clinical Associate Professor
Department of Pharmacy Practice
Binghamton University
School of Pharmacy and Pharmaceutical Sciences
Binghamton, New York
Clinical Associate Professor
Department of Medicine, Division of Infectious Diseases
Upstate Medical University
Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
SUNY Upstate University Hospital
Syracuse, New York 

Kalen B. Manasco, Pharm.D., FCCP, FPPA, BCPS, BCPPS
Clinical Professor
Department of Pharmacotherapy and Translational Research
University of Florida
College of Pharmacy
Clinical Pharmacy Specialist
UF Health Shands
Gainesville, Florida 

Meera J. Mehta, Pharm.D., BCIDP
Infectious Diseases Clinical Specialist
Infectious Diseases PGY2 Residency Assistant Director
Department of Pharmacy
West Virginia University Hospitals
Morgantown, West Virginia 

Cynthia T. Nguyen, Pharm.D., BCIDP
Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University of Chicago Medicine
Chicago, Illinois 

Jessica Smith, Pharm.D., MBA, BCIDP
Specialty Practice Pharmacist, Infectious Diseases
Department of Pharmacy
The Ohio State University Wexner Medical Center
Columbus, Ohio 

Katie J. Suda, Pharm.D., MS, FCCP
Professor and Director Department of Medicine
University of Pittsburgh
Research Health Scientist and Clinical Pharmacy Specialist
Center for Health Equity Research and Promotion
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania 

Kendall J. Tucker, Pharm.D., MS, BCPS, BCIDP
Assistant Professor
Department of Pharmacy Practice
Wilkes University, Nesbitt School of Pharmacy
Wilkes-Barre, Pennsylvania 

C. Dustin Waters, Pharm.D., BCIDP
Infectious Diseases Clinical Pharmacist
Department of Pharmacy
Intermountain Health McKay-Dee Hospital
Ogden, Utah 

Sarah Withers, Pharm.D., MS, BCIDP
Infectious Diseases Clinical Pharmacy Specialist
Prisma Health-Upstate
Affiliate Assistant Professor
U of SC College of Pharmacy
Clinical Assistant Professor
U of SC School of Medicine - Greenville
Greenville, South Carolina

Mohamed Hisham Basheer, Pharm.D., BCCCP, BCIDP
Clinical Pharmacist
Department of Pharmacy Services Cleveland Clinic Abu Dhabi
Abu Dhabi, United Arab Emirates
Clinical Assistant Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio 

Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS
Clinical Professor
Department of Clinical and Administrative Pharmacy
University of Georgia College of Pharmacy
Savannah, Georgia 

Dana R. Bowers, Pharm.D., BCPS, BCIDP
Clinical Assistant Professor
Department of Pharmacotherapy
Washington State University College of Pharmacy and Pharmaceutical Sciences
Yakima, Washington 

Elias B. Chahine, Pharm.D., FCCP, FASCP, FFSHP, BCPS, BCIDP
Professor of Pharmacy Practice
Department of Pharmacy Practice
Palm Beach Atlantic University
Gregory School of Pharmacy
West Palm Beach, Florida
Clinical Pharmacy Specialist
Department of Pharmacy Services
Wellington Regional Medical Center
Wellington, Florida              

Lisa E. Dumkow, Pharm.D., BCIDP
Clinical Pharmacist
Antimicrobial Stewardship Program Director
PGY-2 Infectious Diseases Pharmacy Residency
Department of Pharmacy
Trinity Health Grand Rapids
Grand Rapids, Michigan 

Amy Fabian, Pharm.D., BCPS, BCIDP
Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University Hospitals St. John Medical Center
Westlake, Ohio 

Sandra Smith Garner, Pharm.D., FCCP, BCPS, BCPPS
Professor
Department of Clinical Pharmacy and Outcome Sciences
College of Pharmacy, Medical University of South Carolina
Charleston, South Carolina 

Karla Killgore Smith, Pharm.D., BCPS, BCIDP
Clinical Pharmacy Specialist, Antibiotic Stewardship & Cystic Fibrosis
Cottage Health
Santa Barbara, California
Adjunct Clinical Professor
Thomas J. Long School of Pharmacy and Health Sciences
University of the Pacific
Stockton, California 

Kari A. McCracken, Pharm.D., MBA, BCPS, BCIDP
System Clinical Pharmacy Manager
Infectious Diseases Clinical Pharmacist
Department of Pharmacy
Ascension St John Health System
Tulsa, Oklahoma 

Rachel Musgrove, Pharm.D., BCIDP
Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
St. Joseph’s/Candler Health System
Savannah, Georgia 

Dipti Patel, Pharm.D., BCPS, BCIDP
Clinical Pharmacist, Critical Care
Department of Pharmacy
Southern Regional Medical Center
Riverdale, Georgia 

Anna Poston-Blahnik, Pharm.D., BCIDP, AAHIVP
Clinical Pharmacy Specialist
Infectious Disease / Antimicrobial Stewardship / ID Research
Department of Pharmacy
University of Cincinnati Medical Center – UC Health
Cincinnati, Ohio 

Danya R. Reynolds, Pharm.D., BCPS, BCIDP
Scientific Director, Infectious Diseases
Clinical Care Options
Charlotte, North Carolina 

Brian J. Werth, Pharm.D.
Associate Professor
Department of Pharmacy
University of Washington School of Pharmacy
Seattle, Washington 

Riley J. Williams II, Pharm.D., BCIDP
Clinical Pharmacist Practitioner
Department of Infectious Diseases
Oklahoma City VA Health Care System
Oklahoma City, Oklahoma 

Linda Yang, Pharm.D., BCPS, BCIDP
Clinical Pharmacist Practitioner
Department of Pharmacy
VA North Texas Health Care System
Dallas, Texas 

Min Zhang, Pharm.D., BCPS, BCIDP
Pharmacy Clinical Specialist, Medicine
Department of Pharmacy Services
Boston Medical Center
Boston, Massachusetts
Adjunct Clinical Assistant Professor
College of Pharmacy
University of Rhode Island
Kingston, Rhode Island

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, the American Society of Health-System Pharmacists (ASHP) and the American College of Clinical Pharmacy (ACCP) require that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ACCP and ASHP education activities are qualified and selected by ACCP and ASHP and required to disclose any relevant financial relationships with commercial interests. ACCP and ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

• Consultancies: Christopher M. Bland (Merck); P. Brandon Bookstaver (Spero Therapeutics); David Cluck (Astellas); Aimee Dassner (Medscape; Pediatric Pharmacy Association; Washington University); Wesley Kufel (Theratechnologies); Cynthia Nguyen (Roche Diagnostics); Brian Werth (Shionogi); Riley Williams II (VPR/Sanofi)
• Grants: Wesley Kufel (Melinta; Merck); Katie Suda (AHRQ, VA, NIH)
• Honoraria: Christopher M. Bland (Merck; bioMerieux); Elias Chahine (Sequirus; Gilead; Shionogi; Theratechnologies); Riley Williams II (VPR/Sanofi)
• Consultancies: Elizabeth Dodds-Ashley (Joint Commission Resources; Hospital Association of New York State; MAD-ID) Grants: Elizabeth Dodds-Ashley (University of Maryland; CDC Epicenter and SHEPHERD Grant Programs); Alan Gross (AHRQ) Royalties: Elizabeth Dodds-Ashley (UpToDate)
• Honoraria: Alan Gross (APhA; PROCE)

All other planners, presenters, reviewers, ACCP and ASHP staff and others with an opportunity to control content report no financial relationships relevant to this activity.

Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:

• Complete the attestation statement
• Review all content
• Complete and pass the assessments
• Complete the evaluations

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

ACCP and ASHP collaborate on infectious diseases activities.